Institutional Ownership
Inhibikase Therapeutics Inc
CUSIP 45719W205COM NEWIKTQ1 2026
13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
16.3%
Max % of class reported
Institutional Holders
100
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
21 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Perceptive Advisors LLC | 13G/A | 10.0% | 12.82M | SEC |
| 2 | Feb 17, 2026 | Adar1 Capital Management, LLC | 13G/A | 13.0% | 12.69M | SEC |
| 3 | Feb 17, 2026 | Fairmount Funds Management LLC | 13G/A | 11.0% | 12.46M | SEC |
| 4 | Feb 13, 2026 | Sands Capital Life Sciences Pulse Fund II, L.P. | 13G/A | 10.8% | 13.02M | SEC |
| 5 | Feb 13, 2026 | Nantahala Capital Management, LLC | 13G/A | 5.7% | 7.04M | SEC |
| 6 | Dec 31, 2025 | Trails Edge Capital Partners, LP | 13G | 5.1% | 6.15M | SEC |
| 7 | Aug 14, 2025 | Adar1 Capital Management, LLC | 13G/A | 13.0% | 7.74M | SEC |
| 8 | Aug 13, 2025 | Sands Capital Life Sciences Pulse Fund II, L.P. | 13G/A | 14.7% | 10.95M | SEC |
| 9 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 3.53M | SEC |
| 10 | Feb 14, 2025 | Adar1 Capital Management, LLC | 13G | 13.0% | 6.99M | SEC |
11 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Inhibikase Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | 13.02M | $21.87M |
| 2 | Soleus Capital Management, L.P. | 10.88M | $18.27M |
| 3 | Fairmount Funds Management LLC | 8.63M | $14.49M |
| 4 | Trails Edge Capital Partners, LP | 8.06M | $13.54M |
| 5 | Adar1 Capital Management, LLC | 6.61M | $11.10M |
| 6 | Blackrock, Inc. | 6.30M | $10.59M |
| 7 | Blackstone Inc. | 5.94M | $9.98M |
| 8 | Siren, L.L.C. | 5.85M | $9.83M |
| 9 | Commodore Capital LP | 5.40M | $9.07M |
| 10 | Saturn V Capital Management LP | 3.86M | $6.49M |